
|
DrugPatentWatch concentrates deep knowledge on more than 6,400 small-molecule drugs and 2,300 generic ingredients from 1,700 branded and generic pharmaceutical companies and 700 suppliers, and more than 4,300 active and expired US patents and 74,000 international patents spanning 93 countries and regional patent offices. |
Summary for Generic Name: cephalexin
| |||||||||||||||
Clinical Trials for: cephalexinBioequivalence Study of Cephalexin Tablets 1g Status: Completed Condition: Infections, Respiratory Tract Bioequivalence Study of Cephalexin Suspension 125 Status: Completed Condition: Infections, Respiratory Tract Bioequivalence Study of Cephalexin Suspension 250 Status: Completed Condition: Infections, Respiratory Tract Comparison of Intravenous Cefazolin Plus Oral Probenecid With Oral Cephalexin for the Treatment of Cellulitis Status: Recruiting Condition: Cellulitis Comparison of Cephalexin Versus Clindamycin for Suspected CA-MRSA Skin Infections Status: Completed Condition: Staphylococcal Infection; Abscess; Staphylococcal Skin Infection; Folliculitis Cross Over Study to Prove Bioequivalence Between Two Brands of Cefalexin Suspension Status: Completed Condition: Anti-Infective Agents Cross-over Study to Prove Bioequivalence Between Two Brands of Cefalexin Capsules Status: Completed Condition: Anti-Infective Agents Cross-over Study to Prove Bioequivalence Between Two Brands of Cefalexin Suspension Status: Completed Condition: Anti-Infective Agents A Study to Compare Cefdinir and Cephalexin for the Treatment of Mild to Moderate Uncomplicated Skin Infections Status: Completed Condition: Mild to Moderate Uncomplicated Skin and Skin Structure Infections S9809, Ciprofloxacin Compared With Cephalexin in Treating Patients With Bladder Cancer Status: Terminated Condition: Bladder Cancer Courtesy of ClinicalTrials.org See more clinical trials for this drug | |||||||||||||||
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Type | RLD | Patent No. | Product | Substance | Delist_Flag | Patent Expiration | Exclusivity Expiration | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Lilly | KEFTAB | cephalexin hydrochloride | TABLET; ORAL | 050614 | Oct 29, 1987 | DISCN | No | <disabled> | <disabled> | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Lilly | KEFTAB | cephalexin hydrochloride | TABLET; ORAL | 050614 | May 16, 1988 | DISCN | No | <disabled> | <disabled> | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Lilly | KEFLET | cephalexin | TABLET; ORAL | 062745 | Dec 1, 1986 | DISCN | No | <disabled> | <disabled> | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Lilly | KEFLET | cephalexin | TABLET; ORAL | 050440 | Approved Prior to Jan 1, 1982 | DISCN | No | <disabled> | <disabled> | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| The preview shows a limited data set. Complete access is available with a Subscription | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Export unavailable in trial.
Subscribe for complete access.
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors.
Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided information. There is no warranty that the information contained herein is error free. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.
Copyright © 2002-2013 thinkBiotech LLC. ISSN: 2162-2639
`abc